Progressive Inhibition of Neuromuscular Structure and Neural Tissue Mobilization.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two special therapy techniques to help people who have lumbar radiculopathy, a condition where nerve pain from the lower back spreads down the leg and feels sharp, burning, or electric. The study is looking at whether these therapies—called neural mobilization and Progressive Inhibition of Neuromuscular Structures (PINS)—can reduce pain, improve movement, and lower disability in people with this condition. Neural mobilization involves gently moving the nerve to relieve pain, while PINS uses targeted pressure on muscles and nerves to ease muscle tension and discomfort.
People who might be eligible for this study are adults aged 18 to 40 who have had chronic lumbar radiculopathy for at least three months, specifically affecting one side of the lower back (at the L4-L5 or L5-S1 levels). To join, participants should experience leg pain triggered by certain simple physical tests and must not have more severe or complicated back problems like widespread nerve damage, past spinal surgery, or other serious health concerns. If you join the trial, you can expect to receive these specialized therapy treatments aimed at easing your symptoms and improving your daily function. The study isn’t recruiting yet, but it aims to find better ways to help people with this type of nerve pain.
Gender
ALL
Eligibility criteria
- • INCLUSION CRITERIA
- • Age group between 18 and 40 years(.
- • Both gender male and female.
- • Participants diagnosed as having a chronic (lasting three months or longer) lumbar radiculopathy.
- • Diagnosed patient of having radiculopathy at level of L4-L5 and L5-S1 lesion (unilateral radiculopathy).
- • Radiating pain evoked by specific clinical tests, including slump and straight leg raise.
- Exclusion Criteria:
- • Individuals having bilateral lumbar radiculopathy.
- • Spondylolysis/spondylolisthesis
- • Mechanical systemic low back pain or neoplasmic and infectious processes.
- • Participants with severe nerve root compression (non-ambulant/wheelchair-bound).
- • Any sign or symptom of dementia or other cognitive impairments.
- • Diagnosis of claudication, previous spinal surgery, pregnancy and presence of any of the spinal red flags.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gujrāt, , Pakistan
Patients applied
Trial Officials
Muzna Munir, PhD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported